Statistics for Apixaban-induced cutaneous hypersensitivity: a case series with evidence of cross-reactivity
Total visits
| views | |
|---|---|
| Apixaban-induced cutaneous hypersensitivity: a case series with evidence of cross-reactivity | 99 |
Total visits per month
| views | |
|---|---|
| December 2024 | 0 |
| January 2025 | 0 |
| February 2025 | 0 |
| March 2025 | 1 |
| April 2025 | 0 |
| May 2025 | 0 |
| June 2025 | 0 |
File Visits
| views | |
|---|---|
| java.util.UUID:c59d0fc9-e3c9-4c63-bde2-83e060205f33 | 70 |
| Isaq2020Apixaban-CCBYNCND.pdf | 46 |
| java.util.UUID:5d6352b9-c405-450c-988f-1f0f4b4a2f99 | 13 |
| java.util.UUID:ca8f09f2-c78f-4358-b3fc-53d8a5d931b0 | 6 |
Top country views
| views | |
|---|---|
| United States | 78 |
| Canada | 3 |
| South Korea | 2 |
| Hong Kong SAR China | 1 |
| Japan | 1 |
| Malaysia | 1 |
| Romania | 1 |
| Tunisia | 1 |
Top city views
| views | |
|---|---|
| Wilmington | 46 |
| White Plains | 7 |
| Houston | 5 |
| Fairfield | 4 |
| Ann Arbor | 2 |
| Baltimore | 2 |
| Sherbrooke | 2 |
| Washington | 2 |
| Ashburn | 1 |
| Avon | 1 |
| Bucharest | 1 |
| Cambridge | 1 |
| Central | 1 |
| Indianapolis | 1 |
| Kuala Lumpur | 1 |
| Mount Laurel | 1 |
| Ottawa | 1 |
| Seoul | 1 |
| Tunis | 1 |